This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
EMD Millipore
other brands :
Oncogene Research Products, Calbiochem, Novagen, Merck, Upstate Biotechnology, Chemicon, LINCO, Novabiochem, Guava
product type :
antibody
product name :
TIMP-1 Antibody, clone 147-6D11
catalog :
MAB3301
quantity :
100 µg
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
147-6D11
reactivity :
human
application :
western blot, ELISA, immunohistochemistry, immunohistochemistry - paraffin section, immunohistochemistry - frozen section
citations: 2
Published Application/Species/Sample/Dilution | Reference |
---|---|
| |
product information
Catalog Number :
MAB3301
Subcategory :
Cell Structure
Product Name :
Anti-TIMP-1 Antibody, clone 147-6D11
Product Type :
Antibodies
Clonality :
Monoclonal Antibody
Gene ID :
P01033
Host Name :
Mouse
Antigen :
TIMP-1
Clone :
147-6D11
Conjugate :
Purified
Isotype :
IgG1κ
Product Description :
Anti-TIMP-1 Antibody, clone 147-6D11
Cross Reactivity :
Human Only
ALT Names :
Tissue Inhibitor of Metalloproteinase-1
Immunogen :
Mouse Mac-1
Specificity :
The antibody specifically reacts with human TIMP-1. This is a purified mouse monoclonal antibody to recombinant human tissue inhibitor of metalloproteinases-1 (recombinant TIMP-1).
SPECIES REACTIVITY:
Does not cross-react with mouse and rat TIMP-1.
Package Size :
100 µg
Uses :
ELISA;Western Blotting;Immunohistochemistry (Paraffin)
Storage :
Maintain frozen at -20°C in undiluted aliquots for up to 12 months.
company information
EMD Millipore
290 Concord Road
Billerica, Massachusetts 01821
Billerica, Massachusetts 01821
bioscienceshelp@emdchemical.com
https://www.emdmillipore.com888-854-3417
headquarters: United States
EMD Millipore is the Life Science division of Merck KGaA of Darmstadt, Germany
Hundreds of New Antibodies in the areas of:
View all the new antibodies at www.emdmillipore.com.
Hundreds of New Antibodies in the areas of:
|
|
questions and comments